Search Results - "LAPLANTE, Steven"

Refine Results
  1. 1

    Challenge of Atropisomerism in Drug Discovery by Clayden, Jonathan, Moran, Wesley J, Edwards, Paul J, LaPlante, Steven R

    Published in Angewandte Chemie (International ed.) (01-01-2009)
    “…A twist in the tale: Recent reports have highlighted solutions to the problems encountered when drug candidates exist as slowly interconverting conformers or…”
    Get full text
    Journal Article
  2. 2

    Drug Self-Aggregation into Nano-Entities Has the Potential to Induce Immune Responses by Shahout, Fatma, Vanharen, Marion, Saafane, Abdelaziz, Gillard, James, Girard, Denis, LaPlante, Steven R.

    Published in Molecular pharmaceutics (07-08-2023)
    “…The free-state solution behaviors of small molecules profoundly affect their respective properties. It is becoming more obvious that compounds can adopt a…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Revealing Atropisomer Axial Chirality in Drug Discovery by LaPlante, Steven R., Edwards, Paul J., Fader, Lee D., Jakalian, Araz, Hucke, Oliver

    Published in ChemMedChem (07-03-2011)
    “…An often overlooked source of chirality is atropisomerism, which results from slow rotation along a bond axis due to steric hindrance and/or electronic…”
    Get full text
    Journal Article
  5. 5
  6. 6

    NMR strategies to support medicinal chemistry workflows for primary structure determination by Oguadinma, Paul, Bilodeau, Francois, LaPlante, Steven R.

    Published in Bioorganic & medicinal chemistry letters (15-01-2017)
    “…[Display omitted] Central to drug discovery is the correct characterization of the primary structures of compounds. In general, medicinal chemists make great…”
    Get full text
    Journal Article
  7. 7

    Exposing Small-Molecule Nanoentities by a Nuclear Magnetic Resonance Relaxation Assay by Ayotte, Yann, Marando, Victoria M, Vaillancourt, Louis, Bouchard, Patricia, Heffron, Gregory, Coote, Paul W, Larda, Sacha T, LaPlante, Steven R

    Published in Journal of medicinal chemistry (12-09-2019)
    “…Small molecules can self-assemble in aqueous solution into a wide range of nanoentity types and sizes (dimers, n-mers, micelles, colloids, etc.), each having…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Fragment‐Based Phenotypic Lead Discovery: Cell‐Based Assay to Target Leishmaniasis by Ayotte, Yann, Bilodeau, François, Descoteaux, Albert, LaPlante, Steven R.

    Published in ChemMedChem (18-07-2018)
    “…A rapid and practical approach for the discovery of new chemical matter for targeting pathogens and diseases is described. Fragment‐based phenotypic lead…”
    Get full text
    Journal Article
  10. 10

    NMR spectroscopy can help accelerate antiviral drug discovery programs by LaPlante, Steven R., Coric, Pascale, Bouaziz, Serge, França, Tanos C.C.

    Published in Microbes and infection (01-09-2024)
    “…Small molecule drugs have an important role to play in combating viral infections, and biophysics support has been central for contributing to the discovery…”
    Get full text
    Journal Article
  11. 11

    A Multi-epitope Vaccine Candidate Against Bolivian Hemorrhagic fever Caused by Machupo Virus by Ali, Zeeshan, Cardoza, Jyothsna Volisha, Basak, Srijita, Narsaria, Utkarsh, Bhattacharjee, Surjit, G., Unnati Meher, Isaac, Samuel Paul, Franca, Tanos C. C., LaPlante, Steven R., George, Sudhan S.

    Published in Applied biochemistry and biotechnology (01-04-2024)
    “…Bolivian hemorrhagic fever (BHF) caused by Machupo virus (MACV) is a New World arenavirus having a reported mortality rate of 25–35%. The BHF starts with…”
    Get full text
    Journal Article
  12. 12

    Practical Considerations and Guidelines for Spectral Referencing for Fluorine NMR Ligand Screening by Ayotte, Yann, Woo, Simon, LaPlante, Steven R

    Published in ACS omega (19-04-2022)
    “…Fluorine (19F) NMR strategies are increasingly being employed for evaluating ligand binding to macromolecules, among many other uses. 19F NMR offers many…”
    Get full text
    Journal Article
  13. 13

    Structure-thermodynamics-relationships of hepatitis C viral NS3 protease inhibitors by Wypych, Rachel M., LaPlante, Steven R., White, Peter W., Martin, Stephen F.

    Published in European journal of medicinal chemistry (15-04-2020)
    “…Thermodynamic parameters were determined for structurally-related inhibitors of HCV NS3 protease to assess how binding entropies and enthalpies vary with…”
    Get full text
    Journal Article
  14. 14

    Compound Aggregation in Drug Discovery: Implementing a Practical NMR Assay for Medicinal Chemists by LaPlante, Steven R, Carson, Rebekah, Gillard, James, Aubry, Norman, Coulombe, René, Bordeleau, Sylvain, Bonneau, Pierre, Little, Michael, O’Meara, Jeff, Beaulieu, Pierre L

    Published in Journal of medicinal chemistry (27-06-2013)
    “…The pharmaceutical industry has recognized that many drug-like molecules can self-aggregate in aqueous media and have physicochemical properties that skew…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Probing the free-state solution behavior of drugs and their tendencies to self-aggregate into nano-entities by LaPlante, Steven R., Roux, Valérie, Shahout, Fatma, LaPlante, Gabriela, Woo, Simon, Denk, Maria M., Larda, Sacha T., Ayotte, Yann

    Published in Nature protocols (01-11-2021)
    “…The free-state solution behaviors of drugs profoundly affect their properties. Therefore, it is critical to properly evaluate a drug’s unique multiphase…”
    Get full text
    Journal Article
  17. 17

    Robust Strategy for Hit-to-Lead Discovery: NMR for SAR by Larda, Sacha T., Ayotte, Yann, Denk, Maria M., Coote, Paul, Heffron, Gregory, Bendahan, David, Shahout, Fatma, Girard, Nicolas, Iddir, Mustapha, Bouchard, Patricia, Bilodeau, Francois, Woo, Simon, Farmer, Luc J., LaPlante, Steven R.

    Published in Journal of medicinal chemistry (12-10-2023)
    “…Establishing robust structure–activity relationships (SARs) is key to successful drug discovery campaigns, yet it often remains elusive due to screening and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Molecular modeling of Mannich phenols as reactivators of human acetylcholinesterase inhibited by A-series nerve agents by Vieira, Leandro A., Almeida, Joyce S.F.D., De Koning, Martijn C., LaPlante, Steven R., Borges Jr, Itamar, França, Tanos C.C.

    Published in Chemico-biological interactions (01-09-2023)
    “…The A-series is the most recent generation of chemical warfare nerve agents (CWA) which act directly on the inhibition of the human acetylcholinesterase…”
    Get full text
    Journal Article
  20. 20

    Ligand Bioactive Conformation Plays a Critical Role in the Design of Drugs That Target the Hepatitis C Virus NS3 Protease by LaPlante, Steven R., Nar, Herbert, Lemke, Christopher T., Jakalian, Araz, Aubry, Norman, Kawai, Stephen H.

    Published in Journal of medicinal chemistry (13-03-2014)
    “…A ligand-focused strategy employed NMR, X-ray, modeling, and medicinal chemistry to expose the critical role that bioactive conformation played in the design…”
    Get full text
    Journal Article